| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad3a851c87fb9779cea5332d36fff543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99b73951fd857aaca85ef6a155e3f6de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a355cd8b845d9cf90546141aaa8208e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80cbaaeee718664126e579cf4e41c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb7d7c3a97c434273e4e4138003f909c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e61d591e965f14f0d5962e439a641078 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2008-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6602bac8922ce64cc0992818d8b112b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac51f02196a0c692c828b85d4602744a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b291e83a60bd55240d0a8b7caea4abcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca38446fc51525976852237543cac6d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_262e8b5db8a6696f25df2f3fc90ee491 |
| publicationDate |
2015-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9074254-B2 |
| titleOfInvention |
Method of predicting a predisposition to QT prolongation |
| abstract |
The present invention describes an association between genetic polymorphisms in the ceramide kinase-like (CERKL) gene and a predisposition to prolongation of the QT interval, and provides related methods for the prediction of such a predisposition, the administration of QT interval-prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing QT prolongation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019183873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021186948-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10272076-B2 |
| priorityDate |
2007-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |